OraSure’s Over-The-Counter HIV Test Could Begin Trials This Summer
This article was originally published in The Gray Sheet
Executive Summary
OraSure Technologies expects to launch clinical studies for an over-the-counter indication for its OraQuick Advance rapid HIV test this summer, according to CEO Douglas Michels